Roche to buy Flatiron Health for $1.9 billion to expand cancer care portfolio

(Reuters) – Swiss drugmaker Roche Holding AG said on Thursday it would buy the rest of the privately held U.S. cancer data company Flatiron Health Inc for $1.9 billion to speed up development and delivery of breakthrough medicines for cancer patients.


Source: Reuters

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>